Shah, Jayshri A <br/><br/>
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Mar 2008 
 - 169-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0b013e3282f16d50  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Azathioprine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Inflammatory Bowel Diseases--drug therapy<br/>Medical Audit<br/>Mesalamine--administration & dosage<br/>Methyltransferases--blood<br/>Recurrence<br/>Retrospective Studies<br/>Treatment Outcome